Immune protein levels in rheumatoid arthritis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at levels of certain immune system proteins (IL-6, IL-12, IL-15, and IL-23) in the blood of people with rheumatoid arthritis. It aims to understand how these proteins relate to the disease and may help guide future treatments for better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with rheumatoid arthritis using the latest standard criteria (2010 ACR/EULAR).
- You do not have any other autoimmune disease or connective tissue disease (like lupus, scleroderma, etc.).
- You do not have chronic liver or kidney disease.
- You do not have any genetic disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at specific genetic differences and blood levels of immune proteins to see how they relate to rheumatoid arthritis risk and how active the disease is. It may help researchers understand who is more likely to have rheumatoid arthritis and when the condition is more active.
This study looks at whether a new blood test (anti-PCOLCE) can help diagnose rheumatoid arthritis, especially in people who test negative for standard markers.
This trial measures levels of a protein called CCL-21 in the blood of people with rheumatoid arthritis, osteoarthritis, and healthy volunteers. The goal is to see if CCL-21 levels relate to disease activity and could help track inflammation.
This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.
This study looks for new markers in the blood or breath that could help doctors find and track lung disease in people with rheumatoid arthritis. If you have RA and are over 18, this could help us better understand how lung problems start and how to catch them early.
This trial looks at cardiovascular risk factors in people with rheumatoid arthritis (RA), comparing those who test positive or negative for certain blood markers. It aims to understand how heart health may differ between these groups.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.